According to relevant literatures [14, 38], it might be inferred that the simultaneous inhibition of Bcl-2, Bcl-xL and Mcl-1 might lead to a significant increase of vorinostat induced apoptosis across diverse NSCLC cell types. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.